Loading
OB
Oncolytics Biotech Inc. Stock: price and insider trades · Canada
Oncolytics Biotech Inc.: what insiders have been doing
This page follows insider dealings at Oncolytics Biotech Inc. as filed with SEDI. From 18 October 2025 to 18 October 2026, the disclosure feed for Oncolytics Biotech Inc. logged 17 filings by 14 insiders.
Not one of the filings records a straightforward purchase or sale on the market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
For context, the typical company on the same exchange (median of 2,130 companies) published 12 filings over the same period, against 17 filings here.
Over the last twelve months, not one insider purchase of Oncolytics Biotech Inc. stock was filed. The median gap between a trade and its publication by SEDI is 3 days. The shorter that gap, the sooner other investors can see what insiders have done.
These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.
Insider Decl.
17
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
· cache
Last declaration on 4 June 2026
Declarations17 total
Rights Restricted Share UnitsTSXSEDI:4729532
145,000 shares@ CA$1.06100.0% of flowOptionsTSXSEDI:4729493
OptionsTSXSEDI:4729489
96,000 shares@ CA$1.06100.0% of flowOptionsTSXSEDI:4729467
OptionsTSXSEDI:4729464
260,000 shares@ CA$1.06100.0% of flowOptionsTSXSEDI:4729424
260,000 shares@ CA$1.06100.0% of flowOptionsTSXSEDI:4729421
260,000 shares@ CA$1.06100.0% of flowOptionsTSXSEDI:4729417
755,000 shares@ CA$1.06100.0% of flowOptionsTSXSEDI:4729411
30,000 shares@ CA$1.06100.0% of flowOptionsTSXSEDI:4729408
30,000 shares@ CA$1.06100.0% of flowOptionsTSXSEDI:4729406
30,000 shares@ CA$1.06100.0% of flowOptionsTSXSEDI:4729401
30,000 shares@ CA$1.06100.0% of flowOptionsTSXSEDI:4729399
30,000 shares@ CA$1.06100.0% of flowOptionsTSXSEDI:4729396
30,000 shares@ CA$1.06100.0% of flowOptionsTSXSEDI:4729392
30,000 shares@ CA$1.06100.0% of flowOptionsTSXSEDI:4729381
17 of 17 declarations
About Oncolytics Biotech Inc.
Oncolytics Biotech Inc. is a biotechnology company focused on developing cancer treatments using oncolytic viruses. It is listed on the Toronto Stock Exchange under the symbol ONC.
